Mutant p53 Gain-of-Function in the Spotlight: Are We Suffering a GOF Delusion?

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Mutant p53 proteins are frequently overexpressed in human cancers.
• These mutant proteins have been traditionally considered to possess oncogenic gain-of-function (GOF) properties that drive tumor development.

Purpose of the Study:

• To investigate the actual role of mutant p53 in cancer cell proliferation.
• To challenge the established understanding of mutant p53's oncogenic driver function.

Main Methods:

• Utilized CRISPR technology to precisely remove the TP53-mutant gene.
• Assessed the impact of gene removal on cancer cell growth in both in vitro and in vivo models.

Main Results:

• CRISPR-mediated deletion of the TP53-mutant gene did not affect cancer cell growth.
• This finding held true for both human and mouse cancer cell lines, and across in vitro and in vivo experimental settings.

Conclusions:

• The oncogenic driver role of mutant p53, specifically its gain-of-function properties, is questionable.
• Further research is needed to understand the true biological significance of mutant p53 overexpression in cancer.